USANA Health Sciences Inc. (USNA)
$13.63
$-0.23
(-1.66%)
As on 06-Nov-2026 16:00EST
Market cap
$256 Mln
Revenue (TTM)
$906 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
21.43
-
EV/EBITDA
2.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.1
-
Face value
--
-
Shares outstanding
18,476,534
10 Years Aggregate
CFO
$1,212.49 Mln
EBITDA
$1,585.54 Mln
Net Profit
$934.94 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
| -30.6 | -8.2 | -9.1 | -33.2 | -33.5 | -33.2 | -13.8 |
|
BSE Sensex*
| -4.3 | 11.5 | 3.2 | -2.7 | 7.6 | 6.2 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
| -45.3 | -32.8 | 0.8 | -47.4 | 31.3 | -1.8 | -33.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
13.6 | 256.1 | 905.6 | -21.2 | 0.0 | -2.8 | -- | 0.5 |
| 174.4 | 5,560.5 | 1,109.0 | 170.9 | 20.4 | 13.1 | 32.9 | 4.3 | |
| 50.2 | 8,000.6 | 6,784.9 | 845.6 | 15.6 | 34.4 | 9.6 | 1.7 | |
| 64.4 | 3,112.5 | 1,206.3 | 131.5 | 13.9 | 10.6 | 25.6 | 2.5 | |
| 55.0 | 642.7 | 1,165.1 | 56.4 | 6.8 | 14.9 | 11.5 | 1.7 | |
| 28.5 | 6,793.3 | 18,329.9 | 320.4 | 3.5 | 8.5 | 21.3 | 1.8 | |
| 3,528.2 | 3,379.3 | 10,503.0 | 552.0 | 3.2 | 10.1 | 6.1 | 0.6 | |
| 151.0 | 1,021.1 | 1,800.0 | 118.8 | 9.4 | 15.2 | 8.7 | 1.2 | |
| 148.3 | 1,002.6 | 1,800.0 | 118.8 | 9.4 | 15.2 | 8.6 | 1.3 | |
| 39.0 | 2,937.4 | 731.1 | 83.0 | 11.2 | 8.8 | 31 | 3.1 |
Shareholding Pattern
View DetailsAbout USANA Health Sciences (USNA)
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer.... The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah. Read more
-
Executive Chairman
Mr. Kevin G. Guest
-
Executive Chairman
Mr. Kevin G. Guest
-
Headquarters
Salt Lake City, UT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for USANA Health Sciences (USNA)
What is the current share price of USANA Health Sciences Inc (USNA) Today?
The share price of USANA Health Sciences Inc (USNA) is $13.63 (NYSE) as of 06-Nov-2026 16:00 EST. USANA Health Sciences Inc (USNA) has given a return of -33.5% in the last 3 years.
What is the current PB & PE ratio of USANA Health Sciences Inc (USNA)?
Since, TTM earnings of USANA Health Sciences Inc (USNA) is negative, P/E ratio is not available.
The P/B ratio of USANA Health Sciences Inc (USNA) is 0.50 times as on 06-Nov-2026, a 70 discount to its peers’ median range of 1.67 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
33.39 |
0.67 |
2024 |
16.31 |
1.29 |
2023 |
16.18 |
2.08 |
2022 |
14.78 |
2.36 |
2021 |
17.09 |
5.04 |
What is the 52 Week High and Low of USANA Health Sciences Inc (USNA)?
The 52-week high and low of USANA Health Sciences Inc (USNA) are Rs 23.59 and Rs 12.57 as of 08-Nov-2026.
What is the market cap of USANA Health Sciences Inc (USNA)?
USANA Health Sciences Inc (USNA) has a market capitalisation of $ 256 Mln as on 06-Nov-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in USANA Health Sciences Inc (USNA)?
Before investing in USANA Health Sciences Inc (USNA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.